Filing Details
- Accession Number:
- 0000899243-22-017761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-12 16:18:04
- Reporting Period:
- 2022-05-10
- Accepted Time:
- 2022-05-12 16:18:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1860742 | Bausch & Lomb Corp | BLCO | Pharmaceutical Preparations (2834) | NJ |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 885590 | Bausch Health Companies Inc. | 400 Somerset Corporate Blvd. Bridgewater NJ 08807 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Disposition | 2022-05-10 | 35,000,000 | $17.06 | 315,000,000 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Footnotes
- Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters pursuant to an Underwriting Agreement, dated May 5, 2020, in connection with the initial public offering of the Issuer, which closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022.
- Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person.
Billionaire Hedge Funds
